Th2-Biased Immune System Promotion of Allogeneic Corneal Epithelial Cell Survival after Orthotopic Limbal Transplantation

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 11, 2003, Pages 4736-4741

  Maruyama, Kazuichi ^a   Yamada, Jun ^a,b   Sano, Yoichiro ^a   Kinoshita, Shigeru ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b MEIJI UNIVERSITY OF INTEGRATIVE MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BALANCED SALT SOLUTION; FREUND ADJUVANT; GREEN FLUORESCENT PROTEIN; KEYHOLE LIMPET HEMOCYANIN;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL REGENERATION; CELL SPECIFICITY; CELL SURVIVAL; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA NEOVASCULARIZATION; CORNEA TRANSPLANTATION; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DOSE TIME EFFECT RELATION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSTIMULATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; ORTHOTOPIC LIMBAL TRANSPLANTATION; PRIORITY JOURNAL; SENSITIZATION; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELL SURVIVAL; CELL TRANSPLANTATION; CYTOKINES; EPITHELIUM, CORNEAL; GRAFT SURVIVAL; GREEN FLUORESCENT PROTEINS; HEMOCYANIN; IMMUNE SYSTEM; LIMBUS CORNEAE; LUMINESCENT PROTEINS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; STEM CELL TRANSPLANTATION; TH2 CELLS;

EID: 0142231941     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.02-0718     Document Type: Article

References (22)

1. Thoft RA. Keratoepithelioplasty. Am J Ophthalmol. 1984;97:1-6.
2. Turgeon PW, Nauheim RC, Roat MI, Stopak SS, Thoft RA. Indications for keratoepithelioplasty. Arch Ophthalmol. 1990;108:233-236.
3. Kinoshita S, Ohashi Y, Ohji M, Manabe R. Long-term results of keratoepithelioplasty in Mooren's ulcer. Ophthalmology. 1991;98:438-445.
4. Frangie JP, Leibowitz HM. Steroids. Intl Ophthalmol. 1993;33:9-29.
5. Barraquer J. Immunosuppressive agents in penetrating keratoplasty. Am J Ophthalmol. 1985;100:61-64.
6. Tsubota K, Satake Y, Kaido M, et al. Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation. N Engl J Med. 1999;340:1697-1703.
7. Mills RA, Coster DJ, Williams KA. Effect of immunosuppression on outcome measures in a model of rat limbal transplantation. Invest Ophthalmol Vis Sci. 2002;43:647-655.
8. Yao YF, Inoue Y, Miyazaki D, et al. Ocular resurfacing and alloepithelial rejection in a murine keratoepithelioplasty model. Invest Ophthalmol Vis Sci. 1995;36:2623-2633.
9. Sonoda Y, Streilein JW. Orthotopic corneal transplantation in mice: evidence that the immunogenetic rules of rejection do not apply. Transplantation. 1992;54:694-704.
10. Joo CK, Pepose JS, Stuart PM. T-cell mediated responses in a murine model of orthotopic corneal transplantation. Invest Ophthalmol Vis Sci. 1995;36:1530-1540.
11. Yamada J, Streilein JW. New Insights into prevention of donor-specific corneal graft rejection. Cornea. 2000;19:S177-S182.
12. Miyazaki D, Inoue Y, Yao YF, et al. T-cell-mediated immune responses in alloepithelial rejection after murine keratoepithelioplasty. Invest Ophthalmol Vis Sci. 1999;40:2590-2597.
13. Yao YF, Inoue Y, Miyazaki D, et al. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice. Invest Ophthalmol Vis Sci. 1997;38:292-300.
14. Sano Y, Okamoto S, Streilein JW. Induction of donor-specific ACAID can prolong orthotopic corneal allograft survival in "high-risk" eyes. Curr Eye Res. 1997;16:1171-1174.
15. Sonoda A, Sonoda Y, Muramatu R, Streilein JW, Usui M. ACAID induced by allogeneic corneal tissue promotes subsequent survival of orthotopic corneal grafts. Invest Ophthalmol Vis Sci. 2000;41:790-798.
16. Niederkorn JY, Mellon J. Anterior chamber-associated immune deviation promotes corneal allograft survival. Invest Ophthalmol Vis Sci. 1996;37:2700-2707.
17. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell. 1994;76:241-251.
18. Yamada J, Yoshida M, Taylor AW, Streilein JW. Mice with Th2-biased immune systems accept orthotopic corneal allografts placed in "high risk" eyes. J Immunol. 1999;162:5247-5255.
19. Taylor AW, Streilein JW, Cousins SW. Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr Eye Res. 1992;11:1199-1206.
20. Niederkorn JY. Immune privilege and immune regulation in the eye. Adv Immunol. 1990:48:191-226.
21. Streilein JW. Anterior chamber associated immune deviation: the privilege of immunity in the eye. Surv Ophthalmol. 1990;35:67-73.
22. DeKruyff RH, Fang Y, Umetsu DT. IL-4 synthesis by in vivo primed keyhole limpet hemocyanin-specific CD4+ T cells. I. Influence of antigen concentration and antigen-presenting cell type. J Immunol. 1992;149:3468-3476.